查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1600561

CBD 消費者健康市場：按產品、通路 - 2025-2030 年全球預測

CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

CBD消費健康市場2023年估值為107.7億美元，預計2024年將達到124.6億美元，複合年成長率為15.79%，到2030年將達到300.7億美元。

CBD消費者健康市場被定義為將大麻二酚（CBD）融入健康相關產品的領域，旨在促進消費者健康，涵蓋範圍廣泛。消費者對天然和有機健康替代品的認知推動了這一市場需求，並得到越來越多支持 CBD 治療功效（如緩解疼痛、抗焦慮作用和發炎特性）的研究的支持。應用涵蓋多種產品類型，包括營養食品、個人保健產品和藥品，最終用戶包括注重健康的消費者、運動員和尋求替代療法的患者。主要成長要素包括合法化趨勢、消費者接受度的提高以及電子商務和零售領域分銷管道的加強。最新的商業機會來自於在未開發領域開發創新的 CBD 注入解決方案，例如助眠食品、寵物保健食品和心理健康補充品。公司可以透過投資產品多元化、分銷策略夥伴關係以及消費者教育計劃來增強信譽和信任。然而，局限性仍然存在，包括監管不確定性，特別是 FDA 對 CBD 作為食品添加劑和膳食食品的立場。市場成長挑戰包括確保產品品質和一致性以及不同地區之間法律法規的複雜性。創新和研究的最佳領域包括探索 CBD 和其他植物抽取物之間的協同效應，推進奈米封裝技術以提高生物利用度，以及驗證健康聲明，其中包括進行嚴格的臨床試驗。關注透明度和教育有助於消除消費者的懷疑。市場本質上是動態且不斷發展的，其特點是隨著公司尋求有效的差異化，技術創新迅速，競爭力不斷增強。透過領先新興趨勢並響應監管開拓，公司可以利用不斷擴大的 CBD 健康市場並實現永續的業務成長。

主要市場統計
基準年[2023] 107.7億美元
預測年份 [2024] 124.6億美元
預測年份 [2030] 300.7億美元
複合年成長率（%） 15.79%

市場動態：揭示快速發展的 CBD 消費者健康市場的關鍵市場洞察

CBD 消費者健康市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 各國藥用大麻合法化
    • 對 CBD食品補充劑的需求增加
    • 健康意識不斷提高，越來越多的零售商銷售基於 CBD 的產品
  • 市場限制因素
    • 缺乏劑量資訊以及與其他處方箋的負面交互作用
  • 市場機會
    • 醫療保健領域 CBD 相關研究活動的承諾和投資
    • 藥用 CBD 進出口增加和 CBD 外用製劑的使用擴大
  • 市場挑戰
    • 替代品的可用性、CBD 產品的高價格以及監管問題

波特的五力：駕馭 CBD 消費者健康市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 CBD 消費保健市場的外部影響

外部宏觀環境因素在塑造 CBD 消費者健康市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 CBD 消費者健康市場的競爭格局

對 CBD 消費者健康市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 在 CBD 消費性健康市場的定位矩陣供應商績效評估

FPNV 定位矩陣是評估 CBD 消費者健康市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 各國醫用大麻合法化
      • 對 CBD 營養食品的需求增加
      • 健康意識不斷提高，銷售基於 CBD 的產品的零售商數量不斷增加
    • 抑制因素
      • 缺乏劑量資訊以及與其他處方藥物的不良交互作用
    • 機會
      • 醫療保健領域 CBD 研究工作的承諾和投資
      • 醫用 CBD 進出口增加以及 CBD 外用製劑的使用擴大
    • 任務
      • 替代品的可用性、CBD 產品的高價格以及監管問題
  • 市場區隔分析
    • 產品：含有 CBD 的醫療非處方藥產品因其可用性和人們對其健康益處的認知而廣受歡迎。
    • 通路：消費者線上平台購買 CBD 消費保健品的偏好增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第 6 章 CBD 消費者健康市場：依產品

  • 醫療非處方藥產品
    • CBD止痛藥
    • CBD皮膚科產品
    • CBD心理健康產品
    • CBD助眠產品
  • 食品補充品
    • CBD運動營養
    • CBD 維生素和營養食品
    • CBD體重管理和健康

第7章 CBD 消費保健市場：依通路分類

  • 線上
  • 零售藥房
  • 零售店

第8章美洲 CBD 消費保健市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太CBD消費保健市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的CBD消費保健市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Irwin Naturals 大麻產品在加拿大推出
    • 座艙罩 Growth 加速進入美國大麻市場
    • 瑪莎·史都華 CBD 推出首個品類擴展，推出新的 CBD 健康主題系列

公司名單

  • Endoca BV
  • CBD American Shaman
  • Isodiol International Inc.
  • HEXO Corp.
  • CBDepot sro
  • Curaleaf, Inc.
  • Canopy Growth Corporation
  • Charlotte's Web Holdings, Inc.
  • Columbia Care Inc.
  • Medterra CBD, LLC.
  • Noramco, Inc.
  • Elixinol LLC
  • Jazz Pharmaceuticals, Inc.
  • Aurora Cannabis Inc.
  • Gaia Botanicals, LLC
  • Medical Marijuana, Inc.
  • Kazmira LLC
  • CV Sciences, Inc.
  • Koninklijke DSM NV
  • Global Cannabinoids Inc.
  • CURE Pharmaceutical Holding Corp.
  • Joy Organics LLC
  • NuLeaf Naturals, LLC
  • Croda International PLC
Product Code: MRR-A339DAEFA242

The CBD Consumer Health Market was valued at USD 10.77 billion in 2023, expected to reach USD 12.46 billion in 2024, and is projected to grow at a CAGR of 15.79%, to USD 30.07 billion by 2030.

The CBD consumer health market encompasses a broad scope, defining itself as a sector that integrates cannabidiol (CBD) into health-related products aimed at improving consumer well-being. This market's necessity is driven by increasing consumer awareness regarding natural and organic health alternatives, backed by growing research supporting CBD's therapeutic benefits, such as pain relief, anti-anxiety effects, and anti-inflammatory properties. Applications span various product categories including dietary supplements, personal care products, and pharmaceuticals, with end-users comprising wellness-oriented consumers, athletes, and patients seeking alternative relief options. Key growth influencers include ongoing legalization trends, rising consumer acceptance, and enhanced distribution channels across e-commerce and retail sectors. Latest opportunities arise from developing innovative CBD-infused solutions in underdeveloped areas such as sleep aids, pet wellness, and mental health supplements. Companies can capitalize by investing in product diversification, strategic partnerships for distribution, and consumer education initiatives to bolster credibility and trust. However, limitations remain, including regulatory uncertainties, particularly within the FDA's stance on CBD as a food additive and dietary supplement. Market growth challenges involve the complexity of ensuring product quality and consistency, along with navigating legal restrictions across different regions. Best areas for innovation and research include exploring the synergy of CBD with other botanical extracts, advancing nanoencapsulation techniques to enhance bioavailability, and conducting rigorous clinical trials to substantiate health claims. Emphasizing transparency and education can further help mitigate consumer skepticism. The market is marked by its dynamic and evolving nature, characterized by rapid innovation and competitive advancements as businesses strive to differentiate effectively. By staying ahead of emerging trends and adapting to regulatory developments, companies can leverage the expanding CBD health market for sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 10.77 billion
Estimated Year [2024] USD 12.46 billion
Forecast Year [2030] USD 30.07 billion
CAGR (%) 15.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CBD Consumer Health Market

The CBD Consumer Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Legalization of Cannabis for Medicinal Purpose Across Various Countries
    • Increasing Demand for CBD Nutraceuticals
    • Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
  • Market Restraints
    • Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
  • Market Opportunities
    • Initiatives and Investment taken for Research Activity on CBD in Healthcare
    • Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
  • Market Challenges
    • Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns

Porter's Five Forces: A Strategic Tool for Navigating the CBD Consumer Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CBD Consumer Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CBD Consumer Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CBD Consumer Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CBD Consumer Health Market

A detailed market share analysis in the CBD Consumer Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CBD Consumer Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CBD Consumer Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CBD Consumer Health Market, highlighting leading vendors and their innovative profiles. These include Endoca BV, CBD American Shaman, Isodiol International Inc., HEXO Corp., CBDepot s.r.o, Curaleaf, Inc., Canopy Growth Corporation, Charlotte's Web Holdings, Inc., Columbia Care Inc., Medterra CBD, LLC., Noramco, Inc., Elixinol LLC, Jazz Pharmaceuticals, Inc., Aurora Cannabis Inc., Gaia Botanicals, LLC, Medical Marijuana, Inc., Kazmira LLC, CV Sciences, Inc., Koninklijke DSM N.V., Global Cannabinoids Inc., CURE Pharmaceutical Holding Corp., Joy Organics LLC, NuLeaf Naturals, LLC, and Croda International PLC.

Market Segmentation & Coverage

This research report categorizes the CBD Consumer Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Medical OTC Products and Nutraceuticals. The Medical OTC Products is further studied across CBD Analgesic Products, CBD Dermatology Products, CBD Mental Health Products, and CBD Sleeping Aids Products. The Nutraceuticals is further studied across CBD Sports Nutrition, CBD Vitamins & Dietary Supplements, and CBD Weight Management & Wellbeing.
  • Based on Distribution Channel, market is studied across Online, Retail Pharmacies, and Retail Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Legalization of Cannabis for Medicinal Purpose Across Various Countries
      • 5.1.1.2. Increasing Demand for CBD Nutraceuticals
      • 5.1.1.3. Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
    • 5.1.3. Opportunities
      • 5.1.3.1. Initiatives and Investment taken for Research Activity on CBD in Healthcare
      • 5.1.3.2. Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Popularity of CBD-infused medical OTC products due to easy availability and improved awareness regarding their health benefits
    • 5.2.2. Distribution Channel: Improved consumer preference for buying CBD consumer health products on online platforms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. CBD Consumer Health Market, by Product

  • 6.1. Introduction
  • 6.2. Medical OTC Products
    • 6.2.1. CBD Analgesic Products
    • 6.2.2. CBD Dermatology Products
    • 6.2.3. CBD Mental Health Products
    • 6.2.4. CBD Sleeping Aids Products
  • 6.3. Nutraceuticals
    • 6.3.1. CBD Sports Nutrition
    • 6.3.2. CBD Vitamins & Dietary Supplements
    • 6.3.3. CBD Weight Management & Wellbeing

7. CBD Consumer Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Retail Pharmacies
  • 7.4. Retail Stores

8. Americas CBD Consumer Health Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific CBD Consumer Health Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa CBD Consumer Health Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Irwin Naturals Cannabis Products Launch Nationwide in Canada
    • 11.3.2. Canopy Growth to Fast-Track Entry into the U.S. Cannabis Market
    • 11.3.3. Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals

Companies Mentioned

  • 1. Endoca BV
  • 2. CBD American Shaman
  • 3. Isodiol International Inc.
  • 4. HEXO Corp.
  • 5. CBDepot s.r.o
  • 6. Curaleaf, Inc.
  • 7. Canopy Growth Corporation
  • 8. Charlotte's Web Holdings, Inc.
  • 9. Columbia Care Inc.
  • 10. Medterra CBD, LLC.
  • 11. Noramco, Inc.
  • 12. Elixinol LLC
  • 13. Jazz Pharmaceuticals, Inc.
  • 14. Aurora Cannabis Inc.
  • 15. Gaia Botanicals, LLC
  • 16. Medical Marijuana, Inc.
  • 17. Kazmira LLC
  • 18. CV Sciences, Inc.
  • 19. Koninklijke DSM N.V.
  • 20. Global Cannabinoids Inc.
  • 21. CURE Pharmaceutical Holding Corp.
  • 22. Joy Organics LLC
  • 23. NuLeaf Naturals, LLC
  • 24. Croda International PLC

LIST OF FIGURES

  • FIGURE 1. CBD CONSUMER HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. CBD CONSUMER HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CBD CONSUMER HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CBD CONSUMER HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD ANALGESIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD DERMATOLOGY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD MENTAL HEALTH PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD SLEEPING AIDS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD SPORTS NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD WEIGHT MANAGEMENT & WELLBEING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2023